|
⚲
|
| Keyboard |
| Christopher Morl | |
|---|---|
| Firm | |
| Address | 500 Totten Pond Road 6th Floor Waltham, MA 02451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Deciphera Pharmaceuticals LLC | 021-288027 | Executive Officer | 52.3 M of 52.3 M |
||
| Miragen Therapeutics Inc | 021-251118 | Executive Officer | 25.0 M of 41.1 M |
||
| Miragen Therapeutics Inc | 021-234182 | Executive Officer | 8.5 M of 20.0 M |
||
| Miragen Therapeutics Inc | 021-177167 | Executive Officer | 13.0 M of 20.0 M |
||
| Ambit Biosciences Corp | 021-162560 | Executive Officer | 22.0 M of 30.0 M |
||
| Ambit Biosciences Corp | 021-149178 | Executive Officer | 15.0 M of 15.9 M |
||